NIH clinical trial of investigational vaccine for COVID-19 begins

Study enrolling Seattle-based healthy adult volunteers.

NIH begins study of remdesivir with anti-inflammatory drug to treat COVID-19

Potential repurposed SARS-CoV-2 (COVID-19) infection drugs - RSC Advances (RSC Publishing) DOI:10.1039/D0RA05821A

Phase 1 Trial of Universal Flu Vaccine Candidate Begins

COVID-19 vaccine tested at Emory is safe, generates immune response, early results show

Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains

Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population

Fourth large-scale COVID-19 vaccine trial begins in the United States

Phase III Testing of AstraZeneca COVID-19 Vaccine Candidate Begins

An overview of key potential therapeutic strategies for combat in the COVID-19 battle - RSC Advances (RSC Publishing) DOI:10.1039/D0RA05434H

Investigational COVID-19 vaccine well-tolerated in older adults